|
Originally published In Press as doi:10.1074/jbc.M009674200 on February 14, 2001
J. Biol. Chem., Vol. 276, Issue 22, 19160-19165, June 1, 2001
Zonula Occludens Toxin Structure-Function Analysis
IDENTIFICATION OF THE FRAGMENT BIOLOGICALLY ACTIVE ON TIGHT
JUNCTIONS AND OF THE ZONULIN RECEPTOR BINDING DOMAIN*
Mariarosaria
Di Pierro §,
Ruliang
Lu ,
Sergio
Uzzau¶,
Wenle
Wang ,
Klara
Margaretten ,
Carlo
Pazzani§,
Francesco
Maimone§ , and
Alessio
Fasano **
From the Division of Pediatric Gastroenterology and
Nutrition and Gastrointestinal Pathophysiology Section, Center for
Vaccine Development, ** Department of Physiology, University of Maryland
School of Medicine, Baltimore, Maryland 21201, ¶ Dipartimento di
Scienze Biomediche, Sezione di Microbiologia Sperimentale e Clinica,
Università di Sassari, Sassari, Italy 07100, Centro
Interuniversitario di Ricerca sui Paesi in via di Sviluppo,
Università "La Sapienza," Rome, Italy 07100, and
§ Dipartimento di Anatomia Patologica e di Genetica,
Univerisità degli Studi, Bari, Italy 70126
Zonula occludens toxin (Zot) is an enterotoxin
elaborated by Vibrio cholerae that increases intestinal
permeability by interacting with a mammalian cell receptor with
subsequent activation of intracellular signaling leading to the
disassembly of the intercellular tight junctions. Zot localizes in the
bacterial outer membrane of V. cholerae with subsequent
cleavage and secretion of a carboxyl-terminal fragment in the host
intestinal milieu. To identify the Zot domain(s) directly involved in
the protein permeating effect, several zot gene deletion
mutants were constructed and tested for their biological activity in
the Ussing chamber assay and their ability to bind to the target
receptor on intestinal epithelial cell cultures. The Zot
biologically active domain was localized toward the carboxyl terminus
of the protein and coincided with the predicted cleavage product
generated by V. cholerae. This domain shared a putative receptor-binding motif with zonulin, the Zot mammalian analogue involved in tight junction modulation. Amino acid comparison between the Zot active fragment and zonulin, combined with site-directed mutagenesis experiments, confirmed the presence of an octapeptide receptor-binding domain toward the amino terminus of the
processed Zot.
*
Partially supported by National Institutes of Health Grant
DK-48373 (A. F.) and the European Commission Contract IC18-CT 97-0231 (F. M.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.

To whom correspondence should be addressed: Division of
Pediatric Gastroenterology and Nutrition, University of Maryland School of Medicine, 685 W. Baltimore St., HSF Bldg., Rm. 465, Baltimore, MD
21201. Tel.: 410-328-0812; Fax: 410-328-1072; E-mail:
afasano@umaryland.edu.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Martin, P. Malreddy, T. Iwamoto, L. C. Freeman, H. J. Davidson, J. M. Tomich, and B. D. Schultz
NC-1059: A Channel-Forming Peptide That Modulates Drug Delivery across In Vitro Corneal Epithelium
Invest. Ophthalmol. Vis. Sci.,
July 1, 2009;
50(7):
3337 - 3345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Secco, E. D'Agostini, R. Marzari, M. Licciulli, R. Di Niro, S. D'Angelo, A. R.M. Bradbury, U. Dianzani, C. Santoro, and D. Sblattero
Antibody library selection by the {beta}-lactamase protein fragment complementation assay
Protein Eng. Des. Sel.,
March 1, 2009;
22(3):
149 - 158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Fasano
Physiological, Pathological, and Therapeutic Implications of Zonulin-Mediated Intestinal Barrier Modulation: Living Life on the Edge of the Wall
Am. J. Pathol.,
November 1, 2008;
173(5):
1243 - 1252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Brun, I. Castagliuolo, V. D. Leo, A. Buda, M. Pinzani, G. Palu, and D. Martines
Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis
Am J Physiol Gastrointest Liver Physiol,
February 1, 2007;
292(2):
G518 - G525.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Thomas, A. Sapone, A. Fasano, and S. N. Vogel
Gliadin Stimulation of Murine Macrophage Inflammatory Gene Expression and Intestinal Permeability Are MyD88-Dependent: Role of the Innate Immune Response in Celiac Disease
J. Immunol.,
February 15, 2006;
176(4):
2512 - 2521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Watts, I. Berti, A. Sapone, T. Gerarduzzi, T. Not, R. Zielke, and A. Fasano
Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats
PNAS,
February 22, 2005;
102(8):
2916 - 2921.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. N. Salama, A. Fasano, M. Thakar, and N. D. Eddington
The Impact of {Delta}G on the Oral Bioavailability of Low Bioavailable Therapeutic Agents
J. Pharmacol. Exp. Ther.,
January 1, 2005;
312(1):
199 - 205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Iyer, K. S. Makarova, E. V. Koonin, and L. Aravind
Comparative genomics of the FtsK-HerA superfamily of pumping ATPases: implications for the origins of chromosome segregation, cell division and viral capsid packaging
Nucleic Acids Res.,
October 5, 2004;
32(17):
5260 - 5279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Broughman, R. M. Brandt, C. Hastings, T. Iwamoto, J. M. Tomich, and B. D. Schultz
Channel-forming peptide modulates transepithelial electrical conductance and solute permeability
Am J Physiol Cell Physiol,
June 1, 2004;
286(6):
C1312 - C1323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Campos, E. Martinez, E. Suzarte, B. L. Rodriguez, K. Marrero, Y. Silva, T. Ledon, R. del Sol, and R. Fando
VGJ{phi}, a Novel Filamentous Phage of Vibrio cholerae, Integrates into the Same Chromosomal Site as CTX{phi}
J. Bacteriol.,
October 1, 2003;
185(19):
5685 - 5696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Scrascia, M. Forcillo, F. Maimone, and C. Pazzani
Susceptibility to rifaximin of Vibrio cholerae strains from different geographical areas
J. Antimicrob. Chemother.,
August 1, 2003;
52(2):
303 - 305.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Canchaya, C. Proux, G. Fournous, A. Bruttin, and H. Brussow
Prophage Genomics
Microbiol. Mol. Biol. Rev.,
June 1, 2003;
67(2):
238 - 276.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Marinaro, A. Fasano, and M. T. De Magistris
Zonula Occludens Toxin Acts as an Adjuvant through Different Mucosal Routes and Induces Protective Immune Responses
Infect. Immun.,
April 1, 2003;
71(4):
1897 - 1902.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M G Clemente, S De Virgiliis, J S Kang, R Macatagney, M P Musu, M R Di Pierro, S Drago, M Congia, and A Fasano
Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function
Gut,
February 1, 2003;
52(2):
218 - 223.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|